Vandooren Jennifer, Van Damme Jo, Opdenakker Ghislain
Department of Microbiology and Immunology, Laboratory of Immunobiology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.
Department of Microbiology and Immunology, Laboratory of Immunobiology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.
Prog Brain Res. 2014;214:193-206. doi: 10.1016/B978-0-444-63486-3.00009-8.
The blood-brain barrier (BBB) is a specific structure that is composed of two basement membranes (BMs) and that contributes to the control of neuroinflammation. As long as the BBB is intact, extravasated leukocytes may accumulate between two BMs, generating vascular cuffs. Specific matrix metalloproteinases, MMP-2 and MMP-9, have been shown to cleave BBB beta-dystroglycan and to disintegrate thereby the parenchymal BM, resulting in encephalomyelitis. This knowledge has been added to the molecular basis of the REGA model to understand the pathogenesis of multiple sclerosis, and it gives further ground for the use of MMP inhibitors for the treatment of acute neuroinflammation. MMP-9 is associated with central nervous system inflammation and occurs in various forms: monomers and multimers. None of the various neurological and neuropathologic functions of MMP-9 have been associated with either molecular structure or molecular form, and therefore, in-depth structure-function studies are needed before medical intervention with MMP-9-specific inhibitors is initiated.
血脑屏障(BBB)是一种由两层基底膜(BMs)组成的特殊结构,有助于控制神经炎症。只要血脑屏障保持完整,外渗的白细胞可能会在两层基底膜之间积聚,形成血管套。特定的基质金属蛋白酶,即MMP - 2和MMP - 9,已被证明可切割血脑屏障β - 肌营养不良聚糖,从而使实质基底膜解体,导致脑脊髓炎。这一知识已被纳入REGA模型的分子基础中,以了解多发性硬化症的发病机制,并且为使用MMP抑制剂治疗急性神经炎症提供了进一步的依据。MMP - 9与中枢神经系统炎症相关,以多种形式存在:单体和多聚体。MMP - 9的各种神经和神经病理学功能均与分子结构或分子形式无关,因此,在开始使用MMP - 9特异性抑制剂进行医学干预之前,需要进行深入的结构 - 功能研究。